Synairgen


Synairgen is a University spin-off and public limited company working in drug discovery and biotechnology. It was founded in 2003 by University of Southampton professors Stephen Holgate, Donna Davies and. The company develops drugs for respiratory diseases including COVID-19.
A subsidiary of the company, Synairgen Research Limited, works on research and development.